Three distribution partners to Chinese market:
1. Aiyingdao (Owned by the partner, WHA's shareholder & lender: Mason)
2. Weihai Port International, a Chinese state-owned company ($34m revenue for 3 years)
3. ISDC ($100m revenue for 42 months)
![]()
![]()
Merits:
- Strong business partners from organic milk supply (ODFA), Chinese CNCA licensed infant formula manufacturer, Hong Kong based billionaire backed listed company, Mason;
- Also secured $74m funding to develop CBDG JV to build organic powder dryer facility
- CFDA/SAMR for normal cow infant formula has passed technical evaluation, pending formal approval
- CBDG facility will have produce up to 10,000t milk powder; Blend & Pack has annual capacity of 20 million tins, Blend & Pack produced organic infant formula for Bellamy's
Risks:
- CFDA/SAMR approval, there are 1156 formulas being approved, Only 3 brands were rejected due to suspension of CNCA licence of their manufacturers, no other rejections so far.
- Revenue
- Brand awareness and promotion
It's a speculative stock, business development has been focusing on building vertical integration, now it's time to increase Brand awareness and more importantly increasing Revenue. Once SAMR approval is received, this one is likely to attract more interest.
GLTA.
- Forums
- ASX - By Stock
- WNX
- WHA uptrend sign begins
WHA uptrend sign begins, page-11
-
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WNX (ASX) to my watchlist
|
|||||
Last
3.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.98M |
Open | High | Low | Value | Volume |
3.0¢ | 3.1¢ | 3.0¢ | $48.02K | 1.587M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 10659 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.1¢ | 257351 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 10659 | 0.030 |
4 | 1223886 | 0.028 |
2 | 62053 | 0.027 |
4 | 733186 | 0.026 |
7 | 2215000 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.031 | 257351 | 1 |
0.032 | 1625000 | 3 |
0.033 | 1280000 | 2 |
0.034 | 500000 | 1 |
0.035 | 25538 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
WNX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online